glp 1 addiction GLP-1 medications get at the heart of addiction: study – WashU Medicine GLP-1 Receptor Agonists and Research

FDA-approved for HSDD in premenopausal women with defined efficacy from Phase 3 pivotal trials

Both compounds produce large body-weight reductions in obesity trials, and both are once-weekly subcutaneous injections dominated by gastrointestinal side effects

Authors have reported mild and temporary skin reactions at the injection site, such as redness, itching, or swelling

2002 Aug;7(4):336-9

Similar content being viewed by others Introduction Diabetes is a chronic metabolic disorder involving hyperglycemia and is characterized by defects in insulin secretion, insulin action, or both

Mary Watanabe Person Operating at variance with their utilization management policies